Related Experiment Video
Updated: Aug 1, 2025

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
Published on: December 8, 2023
[Hemophilia therapy in Italy: what the near future promises.]
1Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Centro Emofilia e Trombosi Angelo Bianchi Bonomi, Milano.
Abstract:
In Italy have materialized changes pertaining to the striking progress for replacement and non-replacement therapies in patients with hemophilia A and B. This editorial looks at further progress that is expected to occur in Italy as elsewhere with the approval of two gene therapies for the hemophilias, as well as the forthcoming approval and availability of a new factor VIII product with a very extended plasma half-life that can be administered no more frequently than once weekly.
Related Concept Videos
iPS Cell Differentiation
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Satellite Stem Cells and Muscular Dystrophy
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

